[go: up one dir, main page]

BRPI0612145A2 - inibidor de tubulina e processo para sua preparação - Google Patents

inibidor de tubulina e processo para sua preparação Download PDF

Info

Publication number
BRPI0612145A2
BRPI0612145A2 BRPI0612145-4A BRPI0612145A BRPI0612145A2 BR PI0612145 A2 BRPI0612145 A2 BR PI0612145A2 BR PI0612145 A BRPI0612145 A BR PI0612145A BR PI0612145 A2 BRPI0612145 A2 BR PI0612145A2
Authority
BR
Brazil
Prior art keywords
preparation
tubulin inhibitor
hemifumarate
tubulin
inhibitor
Prior art date
Application number
BRPI0612145-4A
Other languages
English (en)
Inventor
Yanzhong Wu
Jean Schmid
Timothy John Doyle
Jay Thomas Afragola
David Michael Blum
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37074929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0612145(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0612145A2 publication Critical patent/BRPI0612145A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

INIBIDOR DE TUBULINA E PROCESSO PARA SUA PREPARAçãO. A invenção apresenta hemifumarato de 6-cloro-5-{2, 6-difluoro-4-[3- (metilamino) propóxi] fenil}-2-pirazin-2-il-N-[(1S)-2,2,2-trifluoro-1-metiletil] pirimidin-4-amina, que é um inibidor da tubulina utilizável no tratamento de câncer, e processos de preparação do dito hemifumarato.
BRPI0612145-4A 2005-06-13 2006-06-08 inibidor de tubulina e processo para sua preparação BRPI0612145A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69001605P 2005-06-13 2005-06-13
US80278106P 2006-05-24 2006-05-24
PCT/US2006/022574 WO2006138180A1 (en) 2005-06-13 2006-06-08 Tubulin inhibitor and process for its preparation

Publications (1)

Publication Number Publication Date
BRPI0612145A2 true BRPI0612145A2 (pt) 2010-10-19

Family

ID=37074929

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0612145-4A BRPI0612145A2 (pt) 2005-06-13 2006-06-08 inibidor de tubulina e processo para sua preparação

Country Status (12)

Country Link
EP (1) EP1891052A1 (pt)
JP (1) JP2008543838A (pt)
AR (1) AR054392A1 (pt)
AU (1) AU2006259663A1 (pt)
BR (1) BRPI0612145A2 (pt)
CA (1) CA2610416A1 (pt)
GT (1) GT200600257A (pt)
MX (1) MX2007015718A (pt)
PE (1) PE20070114A1 (pt)
SV (1) SV2007002573A (pt)
TW (1) TW200716613A (pt)
WO (1) WO2006138180A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2499152B1 (en) 2009-11-12 2016-06-29 TUBE Pharmaceuticals GmbH Tubulin inhibitors
EP2903436B1 (en) * 2012-09-19 2019-07-17 The Trustees Of The University Of Pennsylvania Heterocyclic compounds and their use for the treatment of neurodegenerative tauopathies
WO2017181974A1 (zh) * 2016-04-20 2017-10-26 苏州苏领生物医药有限公司 五元杂环类化合物及其制备方法、药物组合物和用途
US11623927B2 (en) 2018-03-02 2023-04-11 The Trustees Of The University Of Pennsylvania Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060098368A (ko) * 2003-09-24 2006-09-18 와이어쓰 홀딩스 코포레이션 항암제로서의 6-[(치환된)페닐]트리아졸로피리미딘
JP2007506746A (ja) * 2003-09-24 2007-03-22 ワイス・ホールディングズ・コーポレイション 抗癌剤としての５−アリールピリミジン類

Also Published As

Publication number Publication date
CA2610416A1 (en) 2006-12-28
SV2007002573A (es) 2007-01-03
AU2006259663A1 (en) 2006-12-28
JP2008543838A (ja) 2008-12-04
EP1891052A1 (en) 2008-02-27
GT200600257A (es) 2007-02-14
PE20070114A1 (es) 2007-02-03
AR054392A1 (es) 2007-06-20
TW200716613A (en) 2007-05-01
MX2007015718A (es) 2008-02-21
WO2006138180A1 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
BRPI0513709A (pt) processo para a fotoativação e uso de um catalisador por um procedimento de dois estágios invertido
BR0313373B1 (pt) processo para fabricação contìnua de artigos descartáveis de vestir.
BRPI0408922B1 (pt) processo para o tratamento termomecánico de aço.
DE602006020327D1 (de) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminder-hemmer zur behandlung thromboembolischer erkrankungen
BR0211293B1 (pt) processo para produzir continuamente uma composição elastomérica.
BR0311232B1 (pt) aparelho de revestimento e processo para o revestimento de plasma de peÇas de trabalho.
CL2007003797A1 (es) Compuestos derivados de pirrolo piridina; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la enfermedad de alzheimer, parkinson, cancer, entre otras enfermedades.
BRPI0519496A2 (pt) processo para preparar um composto ou uma composiÇço, e, composiÇço
EG25039A (en) Process for preparation of compounds used for inhibition of one or more tyrosine kinases.
CL2004001399A1 (es) Catalizador para la hidrogenacion de un compuesto organico que comprende un compuesto de paladio soportado en un material de soporte de alumina, donde dicho catalizador comprende un compuesto de lantanido; y proceso de hidrogenacion que comprende dic
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
BRPI0719955A2 (pt) Processo para síntese de derivados de fenóxi diaminopirimidina
BRPI0516555A (pt) processo de revestimento
GEP20125586B (en) Novel method for synthesis of (7-methoxy-l-naphthyl)-acetonitrile and application thereof in synthesis of agomelatine
NO20076186L (no) Mitotiske kinesininhibitorer og fremgangsmater for anvendelse derav
BR0307184B1 (pt) processo contÍnuo de hidrogenaÇço de compostos.
BR0200574B1 (pt) Processo para hidroprocessar alimentação de hidrocarboneto antecendentes da invenção
BRPI0612145A2 (pt) inibidor de tubulina e processo para sua preparação
MXPA03008674A (es) Procedimiento para la hidrogenacion de compuestos de carbonilo.
GT200800066A (es) Derivados de 9-cloro-15-deoxiprostaglandina, procedimiento para su preparacion y su uso como medicamento.
ITRM20050047A1 (it) Procedimento per la produzione di energia e apparato per la sua attuazione.
BRPI0400563A (pt) Unidade de construção de um dispositivo de engate e processo para a fabricação da unidade de construção
BRPI0606872A2 (pt) uso de pirimidilaminobenzamidas para o tratamento de doenças que respondem à modulação de atividade de tie-2 quinase
GT200600010A (es) Procedimientos para la preparacion de alcoholes aminoetoxibencilicos
BR0212790B1 (pt) processo para restauração da aparência de um artigo.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired